IPPRA / Grant Monitor

2026-07-07
3296Open opportunities
87IPPRA ≥ 60
0Not yet characterized
547Awaiting detail
2026-07-07Last fetch
Lens
Open browse IPPRA Tom Love Innovation Hub Physical Sciences & Engineering (demo) My focus
Deadline
All open ≤ 30 d ≤ 90 d 60+ d 2–6 mo 6–12 mo 12+ mo No deadline
Score
All 80+ 60+ 40+ Unprocessed
Funds
All applied research 27 basic research 11 evaluation research 7 training education 4 other 1 data infrastructure 1
Topic
All national security defense 8 computing communications 7 water resources 5 environment 5 materials manufacturing 4 economic development 4 ai data science 4 public health 3 oceans fisheries 3 biomedical clinical 3 arts humanities culture 3 transportation infrastructure 2 space aeronautics 2 social services 2
Category
All Health 1
IPPRA fit Opportunity Topics Ceiling Posted Closes Days
35 Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required) PAR-25-226 · National Institutes of Health · other biomedical clinical public health mental behavioral health — 2024-11-22 2026-11-19 135

1 OF 1 ROWS